|
시장보고서
상품코드
1983173
비강 약물 전달 시스템 시장 : 제형별, 용기 유형별, 시스템 유형별, 치료 용도별, 유통 채널별, 지역별Nasal Drug Delivery Systems Market, By Dosage Form, By Container Type, By System Type, By Therapeutics Application, By Distribution Channel, By Geography |
||||||
비강 약물 전달 시스템 시장은 2026년에 983억 달러로 추정되며, 2033년에는 1,346억 7,000만 달러에 이를 것으로 예측됩니다. 또한, 2026-2033년 CAGR 8.2%로 성장할 전망입니다.
| 분석 범위 | 분석 상세 | ||
|---|---|---|---|
| 기준 연도 | 2025년 | 시장 규모(2026년) | 983억 달러 |
| 실적 데이터 | 2020-2024년 | 예측 기간 | 2026-2033년 |
| 예측 기간 CAGR(2025-2032년) | 8.20% | 예측 금액(2033년) | 1,346억 7,000만 달러 |
비강은 간에서의 1차 통과 대사를 피할 수 있다는 점과 무엇보다 환자의 편의성이라는 장점으로 인해 가장 잠재력 있고 유망한 약물 전달 경로 중 하나로 떠오르고 있습니다. 비강 약물 전달 시스템은 통증 치료, 급성 편두통 치료, 알레르기성 및 비알레르기성 비염, 부비동염, 감기 또는 비염으로 인한 코 막힘을 치료하는 데 사용되고 있습니다. 비강 내 약물 전달은 일반적으로 빠른 약효 발현이 요구되거나 다른 투여 경로가 효과를 나타내지 않는 경우에 채택됩니다. 비강 약물 전달 시스템을 이용하여 전신 약물 투여 및 무침 면역화가 가능합니다. 액체 비강 내 제제 투여에는 흡입기, 비강 점적기, 스프레이 펌프, 분무기, 분무기 또는 분무기를 사용할 수 있습니다.
시장 역학
비강 약물 전달 시스템에 대한 R&D 활동 증가는 예측 기간 동안 세계 비강 약물 전달 시스템 시장의 성장을 견인할 것으로 예측됩니다. 예를 들어, 2022년 4월 5일 영국에 본사를 둔 위탁개발생산기관(CDMO)인 어퍼톤 파마 솔루션즈(Upperton Pharma Solutions)는 중소 혁신기업이 비강투여 제제 개발에 필요한 지식과 역량을 활용할 수 있도록 비강투여 개발 플랫폼 '어퍼노즈(UpperNose)'를 런칭했습니다. UpperNose'를 런칭하였습니다.
또한, 규제 당국의 제품 승인 증가는 예측 기간 동안 비강 약물 전달 시장의 성장을 견인할 것으로 예측됩니다. 예를 들어, 2021년 10월 18일, 미국 식품의약국(FDA)이 안구건조증 징후 및 증상 치료제로 TYRVAYA(바레니클린 용액) 비강 분무제 0.03mg을 승인했다고 발표하였습니다. 승인했습니다. TYRVAYA 비강 스프레이는 안구건조증 치료제로 승인된 최초이자 유일한 비강 스프레이입니다. TYRVAYA 점안액은 콜린성 수용체에 결합하여 3차신경 부교감신경 경로를 활성화하고, 그 결과 안구건조증 치료제로서 기초 눈물의 생성을 증가시키는 것으로 알려져 있습니다.
본 보고서의 주요 특징
- 세계의 비강 약물 전달 시스템 시장에 대해 조사 분석했으며, 2024년을 기준 연도로 하여 예측 기간(2025-2032년) 시장 규모와 연평균 성장률(CAGR)에 대해 조사 분석하여 전해드립니다.
- 또한, 각 부문의 잠재적 수익 기회를 밝히고, 이 시장의 매력적인 투자 제안 매트릭스를 설명합니다.
- 또한, 시장 촉진 및 억제요인 및 기회, 신제품 출시 및 승인, 시장 동향, 지역별 전망, 주요 업체들의 경쟁 전략 등에 대한 중요한 고찰을 제공합니다.
- 세계 비강 약물 전달 시스템 시장의 주요 기업 프로파일을 기업 개요, 제품 포트폴리오, 주요 특징, 재무 성과, 전략 등 다양한 매개 변수를 기반으로 분석합니다.
- 이 보고서의 인사이트를 통해 마케팅 담당자와 기업 경영진은 향후 제품 출시, 유형 업데이트, 시장 확대, 마케팅 전략에 대한 정보에 입각한 의사결정을 내릴 수 있습니다.
- '세계 비강 약물 전달 시스템 시장' 보고서는 투자자, 공급업체, 제품 제조업체, 유통업체, 신규 시장 진출기업, 재무 분석가 등 업계의 다양한 이해관계자를 대상으로 합니다.
- 이해관계자들은 세계 비강 약물 전달 시스템 시장 분석에 사용되는 다양한 전략 매트릭스를 통해 의사결정을 용이하게 할 수 있습니다.
목차
제1장 조사 목적과 전제조건
제2장 시장 범위
제3장 시장 역학, 규제 및 동향 분석
제4장 세계의 비강 약물 전달 시스템 시장 : 제형별(2026년-2033년)
제5장 세계의 비강 약물 전달 시스템 시장 : 용기 유형별(2026년-2033년)
제6장 세계의 비강 약물 전달 시스템 시장 : 시스템 유형별(2026년-2033년)
제7장 세계의 비강 약물 전달 시스템 시장 : 치료 용도별(2026년-2033년)
제8장 세계의 비강 약물 전달 시스템 시장 : 유통 채널별(2026년-2033년)
제9장 세계의 비강 약물 전달 시스템 시장 : 지역별(2026년-2033년)
제10장 경쟁 구도
제11장 애널리스트 추천
제12장 참고 문헌이 및 분석 방법
LSH 26.04.17Nasal Drug Delivery Systems Market is estimated to be valued at USD 98.3 Bn in 2026 and is expected to reach USD 134.67 Bn by 2033, growing at a compound annual growth rate (CAGR) of 8.2% from 2026 to 2033.
| Report Coverage | Report Details | ||
|---|---|---|---|
| Base Year: | 2025 | Market Size in 2026: | USD 98.3 Bn |
| Historical Data for: | 2020 To 2024 | Forecast Period: | 2026 To 2033 |
| Forecast Period 2026 to 2033 CAGR: | 8.20% | 2033 Value Projection: | USD 134.67 Bn |
Nasal cavity is becoming one of the most potential and promising route of drug delivery, owing to its advantages such as bypassing the hepatic first-pass metabolism, and most importantly patient convenience. The nasal drug delivery systems used in the treatment of pain, acute migraine treatment, allergic and non-allergic rhinitis, and nasal congestion brought on by sinusitis, the common cold, or rhinitis. Nasal medication delivery is typically employed when a beginning of action is desired or when other routes of administration prove unsuccessful. Systemic drug administration and needle-free immunization is possible with the help of nasal drug delivery systems. It is possible to use inhalers, droppers, spray pumps, nebulizers, or atomizers to give liquid nasal solutions.
Market Dynamics
Increasing research and development activities for nasal drug delivery systems is expected to drive growth of the global nasal drug delivery system market over the forecast period. For instance, on April 5, 2022, Upperton Pharma Solutions, a U.K. based contract development and manufacturing organization (CDMO) had launched a nasal delivery development platform, UpperNose, for small and mid-sized innovators to access the knowledge and capabilities required for the successful development of nasal dose formulations.
Furthermore, increasing product approvals by regulatory authorities is expected to drive growth of the nasal drug delivery market over the forecast period. For instance, on October 18, 2021, Oyster Point Pharma, Inc., a commercial-stage biopharmaceutical company had announced that the U.S. Food and Drug Administration (FDA) had approved TYRVAYA (varenicline solution) Nasal Spray 0.03 mg for the treatment of the signs and symptoms of dry eye disease. TYRVAYA Nasal Spray is the first and only nasal spray approved for the treatment of dry eye disease. TYRVAYA Nasal Spray is believed to bind to cholinergic receptors to activate the trigeminal parasympathetic pathway resulting in increased production of basal tear film as a treatment for dry eye disease.
Key features of the study
- This report provides an in-depth analysis of the global nasal drug delivery systems market, and provides market size (USD Bn) and compound annual growth rate (CAGR%) for the forecast period (2026-2033), considering 2025 as the base year
- It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
- This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players
- It profiles key players in the global nasal drug delivery systems market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies
- Key companies covered as a part of this study include Merck & Co., Inc., GlaxoSmithKline plc, AstraZeneca plc, Johnson & Johnson, Pfizer Inc., Baxter International, Inc., Valeant Pharmaceuticals International, Inc., Becton, Dickinson and Company, and Novartis AG
- Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
- The global nasal drug delivery systems market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
- Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global nasal drug delivery systems market
Market Segmentation
- By Dosage Form
- Nasal Spray
- Nasal Drops
- Nasal Gels
- Nasal Powders
- Others
- By Container Type
- Non-pressurized Containers
- Pressurized Containers
- By System Type
- Multi Dose
- Bi Dose
- Unit Dose
- By Therapeutics Application
- Allergic and Non-allergic Rhinitis
- Nasal Congestion
- Vaccination
- Others
- By Distribution Channel
- Hospitals Pharmacies
- Retail Pharmacies
- Online Pharmacies
- By Regional Insights
- North America
- U.S.
- Canada
- Latin America
- Brazil
- Argentina
- Mexico
- Rest of Latin America
- Europe
- Germany
- U.K.
- Spain
- France
- Italy
- Russia
- Rest of Europe
- Asia Pacific
- China
- India
- Japan
- Australia
- South Korea
- ASEAN
- Rest of Asia Pacific
- Middle East
- GCC Countries
- Israel
- Rest of Middle East
- Africa
- South Africa
- North Africa
- Central Africa
- Key Players Insights
- Merck & Co., Inc.
- GlaxoSmithKline plc
- AstraZeneca plc
- Johnson & Johnson
- Pfizer Inc.
- Baxter International, Inc.
- Valeant Pharmaceuticals International, Inc.
- Becton
- Dickinson and Company
- Novartis AG
Table of Contents
1. Research Objectives and Assumptions
- Research Objectives
- Assumptions
- Abbreviations
2. Market Purview
- Report Description
- Market Definition and Scope
- Executive Summary
- Market Snippet, By Dosage Form
- Market Snippet, By Container Type
- Market Snippet, By System Type
- Market Snippet, By Therapeutics Application
- Market Snippet, By Distribution Channel
- Market Snippet, By Region
- Coherent Opportunity Map (COM)
3. Market Dynamics, Regulations, and Trends Analysis
- Market Dynamics
- Drivers
- Restraints
- PEST Analysis
- PORTER's Five Forces Analysis
- Market Opportunities
- Regulatory Scenario
- Key Developments
- Industry Trend
4. Global Nasal Drug Delivery Systems Market, By Dosage Form, 2026-2033, (USD Bn)
- Introduction
- Market Share Analysis, 2025, 2028, and 2033 (%)
- Y-o-Y Growth Analysis, 2021 - 2033
- Segment Trends
- Nasal Spray
- Market Share Analysis, 2025, 2028, and 2033 (%)
- Y-o-Y Growth Analysis, 2021 - 2033
- Segment Trends
- Nasal Drops
- Market Share Analysis, 2025, 2028, and 2033 (%)
- Y-o-Y Growth Analysis, 2021 - 2033
- Segment Trends
- Nasal Gels
- Market Share Analysis, 2025, 2028, and 2033 (%)
- Y-o-Y Growth Analysis, 2021 - 2033
- Segment Trends
- Nasal Powders
- Market Share Analysis, 2025, 2028, and 2033 (%)
- Y-o-Y Growth Analysis, 2021 - 2033
- Segment Trends
- Others
- Market Share Analysis, 2025, 2028, and 2033 (%)
- Y-o-Y Growth Analysis, 2021 - 2033
- Segment Trends
5. Global Nasal Drug Delivery Systems Market, By Container Type, 2026-2033, (USD Bn)
- Introduction
- Market Share Analysis, 2025, 2028, and 2033 (%)
- Y-o-Y Growth Analysis, 2021 - 2033
- Segment Trends
- Non-pressurized Containers
- Market Share Analysis, 2025, 2028, and 2033 (%)
- Y-o-Y Growth Analysis, 2021 - 2033
- Segment Trends
- Pressurized Containers
- Market Share Analysis, 2025, 2028, and 2033 (%)
- Y-o-Y Growth Analysis, 2021 - 2033
- Segment Trends
6. Global Nasal Drug Delivery Systems Market, By System Type, 2026-2033, (USD Bn)
- Introduction
- Market Share Analysis, 2025, 2028, and 2033 (%)
- Y-o-Y Growth Analysis, 2021 - 2033
- Segment Trends
- Multi Dose
- Market Share Analysis, 2025, 2028, and 2033 (%)
- Y-o-Y Growth Analysis, 2021 - 2033
- Segment Trends
- Bi Dose
- Market Share Analysis, 2025, 2028, and 2033 (%)
- Y-o-Y Growth Analysis, 2021 - 2033
- Segment Trends
- Unit Dose
- Market Share Analysis, 2025, 2028, and 2033 (%)
- Y-o-Y Growth Analysis, 2021 - 2033
- Segment Trends
7. Global Nasal Drug Delivery Systems Market, By Therapeutic Application, 2026-2033, (USD Bn)
- Introduction
- Market Share Analysis, 2025, 2028, and 2033 (%)
- Y-o-Y Growth Analysis, 2021 - 2033
- Segment Trends
- Allergic and Non-allergic Rhinitis
- Market Share Analysis, 2025, 2028, and 2033 (%)
- Y-o-Y Growth Analysis, 2021 - 2033
- Segment Trends
- Nasal Congestion
- Market Share Analysis, 2025, 2028, and 2033 (%)
- Y-o-Y Growth Analysis, 2021 - 2033
- Segment Trends
- Vaccination
- Market Share Analysis, 2025, 2028, and 2033 (%)
- Y-o-Y Growth Analysis, 2021 - 2033
- Segment Trends
- Others
- Market Share Analysis, 2025, 2028, and 2033 (%)
- Y-o-Y Growth Analysis, 2021 - 2033
- Segment Trends
8. Global Nasal Drug Delivery Systems Market, By Distribution Channel, 2026-2033, (USD Bn)
- Introduction
- Market Share Analysis, 2025, 2028, and 2033 (%)
- Y-o-Y Growth Analysis, 2021 - 2033
- Segment Trends
- Hospital Pharmacies
- Market Share Analysis, 2025, 2028, and 2033 (%)
- Y-o-Y Growth Analysis, 2021 - 2033
- Segment Trends
- Retail Pharmacies
- Market Share Analysis, 2025, 2028, and 2033 (%)
- Y-o-Y Growth Analysis, 2021 - 2033
- Segment Trends
- Online Pharmacies
- Market Share Analysis, 2025, 2028, and 2033 (%)
- Y-o-Y Growth Analysis, 2021 - 2033
- Segment Trends
9. Global Nasal Drug Delivery Systems Market, By Region, 2026-2033, (USD Bn)
- Introduction
- Market Share Analysis, By Region, 2025, 2028, and 2033 (%)
- Y-o-Y Growth Analysis, For Region, 2021 - 2033
- North America
- Market Share Analysis, By Country, 2025, 2028 and 2033 (%)
- Y-o-Y Growth Analysis, For Country, 2021 - 2033
- Market Size and Forecast, By Dosage Form, 2026- 2033, (USD Bn)
- Market Size and Forecast, By Container Type, 2026- 2033, (USD Bn)
- Market Size and Forecast, By System Type, 2026- 2033, (USD Bn)
- Market Size and Forecast, By Therapeutics Application, 2026- 2033, (USD Bn)
- Market Size and Forecast, By Distribution Channel, 2026- 2033, (USD Bn)
- Market Size and Forecast, By Country, 2026- 2033, (USD Bn)
- U.S.
- Canada
- Latin America
- Market Share Analysis, By Country, 2025, 2028 and 2033 (%)
- Y-o-Y Growth Analysis, For Country, 2021 - 2033
- Market Size and Forecast, By Dosage Form, 2026- 2033, (USD Bn)
- Market Size and Forecast, By Container Type, 2026- 2033, (USD Bn)
- Market Size and Forecast, By System Type, 2026- 2033, (USD Bn)
- Market Size and Forecast, By Therapeutics Application, 2026- 2033, (USD Bn)
- Market Size and Forecast, By Distribution Channel, 2026- 2033, (USD Bn)
- Market Size and Forecast, By Country, 2026- 2033, (USD Bn)
- Brazil
- Argentina
- Mexico
- Rest of Latin America
- Europe
- Market Share Analysis, By Country, 2025, 2028 and 2033 (%)
- Y-o-Y Growth Analysis, For Country, 2021 - 2033
- Market Size and Forecast, By Dosage Form, 2026- 2033, (USD Bn)
- Market Size and Forecast, By Container Type, 2026- 2033, (USD Bn)
- Market Size and Forecast, By System Type, 2026- 2033, (USD Bn)
- Market Size and Forecast, By Therapeutics Application, 2026- 2033, (USD Bn)
- Market Size and Forecast, By Distribution Channel, 2026- 2033, (USD Bn)
- Market Size and Forecast, By Country, 2026- 2033, (USD Bn)
- U.K.
- Germany
- Italy
- France
- Spain
- Russia
- Rest of Europe
- Asia Pacific
- Market Share Analysis, By Country, 2025, 2028 and 2033 (%)
- Y-o-Y Growth Analysis, For Country, 2021 - 2033
- Market Size and Forecast, By Dosage Form, 2026- 2033, (USD Bn)
- Market Size and Forecast, By Container Type, 2026- 2033, (USD Bn)
- Market Size and Forecast, By System Type, 2026- 2033, (USD Bn)
- Market Size and Forecast, By Therapeutics Application, 2026- 2033, (USD Bn)
- Market Size and Forecast, By Distribution Channel, 2026- 2033, (USD Bn)
- Market Size and Forecast, By Country, 2026- 2033, (USD Bn)
- China
- India
- Japan
- ASEAN
- Australia
- South Korea
- Rest of Asia Pacific
- Middle East
- Market Share Analysis, By Country, 2025, 2028 and 2033 (%)
- Y-o-Y Growth Analysis, For Country, 2021 - 2033
- Market Size and Forecast, By Dosage Form, 2026- 2033, (USD Bn)
- Market Size and Forecast, By Container Type, 2026- 2033, (USD Bn)
- Market Size and Forecast, By System Type, 2026- 2033, (USD Bn)
- Market Size and Forecast, By Therapeutics Application, 2026- 2033, (USD Bn)
- Market Size and Forecast, By Distribution Channel, 2026- 2033, (USD Bn)
- Market Size and Forecast, By Country, 2026- 2033, (USD Bn)
- GCC Countries
- Israel
- Rest of Middle East
- Africa
- Market Share Analysis, By Country/Region, 2025, 2028 and 2033 (%)
- Y-o-Y Growth Analysis, For Country/Region, 2021 - 2033
- Market Size and Forecast, By Dosage Form, 2026- 2033, (USD Bn)
- Market Size and Forecast, By Container Type, 2026- 2033, (USD Bn)
- Market Size and Forecast, By System Type, 2026- 2033, (USD Bn)
- Market Size and Forecast, By Therapeutics Application, 2026- 2033, (USD Bn)
- Market Size and Forecast, By Distribution Channel, 2026- 2033, (USD Bn)
- Market Size and Forecast, By Country, 2026- 2033, (USD Bn)
- South Africa
- North Africa
- Central Africa
10. Competitive Landscape
- Heat Map Analysis
- Market Share Analysis (3x3 Matrix)
- Company Profiles
- Merck & Co., Inc.
- Company Overview
- Product Type Portfolio
- Recent Developments/Updates
- GlaxoSmithKline plc
- Company Overview
- Product Type Portfolio
- Recent Developments/Updates
- AstraZeneca plc
- Company Overview
- Product Type Portfolio
- Recent Developments/Updates
- Johnson & Johnson
- Company Overview
- Product Type Portfolio
- Recent Developments/Updates
- Pfizer Inc.
- Company Overview
- Product Type Portfolio
- Recent Developments/Updates
- Baxter International, Inc.
- Company Overview
- Product Type Portfolio
- Recent Developments/Updates
- Valeant Pharmaceuticals International, Inc.
- Company Overview
- Product Type Portfolio
- Recent Developments/Updates
- Becton
- Company Overview
- Product Type Portfolio
- Recent Developments/Updates
- Dickinson and Company
- Company Overview
- Product Type Portfolio
- Recent Developments/Updates
- Novartis AG
- Company Overview
- Product Type Portfolio
- Recent Developments/Updates
- Merck & Co., Inc.
11. Analyst Recommendation
- Wheel of Fortune
- Analyst View
- Coherent Opportunity Map
12. Section
- References
- Research Methodology
- About Us and Sales Contact
